colonoscopy and semaglutide Can Cause Colitis? Evidence Warning Signs Holding GLP-1 Prior to Colonoscopy:

doi: 10.1007/s12011-023-03616-0 27 DaragAKlimczakMStragierowiczJStasikowska-KanickaOKilanowiczA

The glucagon receptor activation drives hepatic fat oxidation in ways that dual agonists do not replicate

In addition, tirzepatide 15mg/weekly led to a -24.7lb weight reduction among T2D subjects, almost double the weight loss observed with 1mg/weekly semaglutide (-12.6lb)

Learn more about our team

Phylum-level analyses indicate predominant Firmicutes with relative Bacteroidetes reduction in some studies (264, 265), while others report increased Actinobacteria , Verrucomicrobia , or pro-inflammatory Proteobacteria , alongside potential reduction of beneficial Bacteroidetes and Actinobacteria ( 262, 266)

Between 2019 and 2023, use of GLP-1 receptor agonists among U.S